AWS Clients End Tokenmaxxing After AI Costs Surge; Pathology AI Hits $68.81M, Automation Market to $96.98B
AMZN•Corporate clients have abandoned tokenmaxxing after inflated AI token invoices, shifting to ML workloads on AWS. The AI pathology market is set to jump from $28.75M to $68.81M by 2035 (9.12% CAGR), and software-defined automation to climb from $46.63B to $96.98B by 2030 (15.7% CAGR), underpinning surging cloud infrastructure demand.
1. Shift Away from Tokenmaxxing
Amazon’s corporate customers have moved away from tokenmaxxing—overusing AI tokens to boost internal metrics—after receiving unexpectedly high bills, leading to optimized ML workload deployments on AWS and cost containment strategies.
2. AI Pathology Market Expansion
The AI in pathology sector, valued at $28.75 million in 2025, is projected to reach $68.81 million by 2035 at a 9.12% CAGR, highlighting a growing use case for AWS healthcare analytics and specialized cloud services.
3. Software-Defined Automation Opportunity
The software-defined automation market is forecast to grow from $46.63 billion in 2025 to $96.98 billion by 2030 (15.7% CAGR), driving increased demand for scalable cloud infrastructure and supporting AWS’s position in enterprise automation solutions.
